FDA-approved
Heart & blood
Desmopressin
Evidence
FDA approved
Class
Vasopressin analog
KEY TAKEAWAY
Desmopressin is a synthetic analog of vasopressin with a stronger effect on urine concentration and a weaker effect on blood pressure. It is sold as DDAVP. The FDA has approved desmopressin (DDAVP) for central diabetes insipidus, certain bleeding disorders and bedwetting.
Written by the Veylo editorial team · Updated
November 2026
What it is
Vasopressin analog
Approved for
Diabetes insipidus, bedwetting and mild hemophilia A or von Willebrand disease
Key fact
The FDA has approved desmopressin (DDAVP) for central diabetes insipidus, certain bleeding disorders and bedwetting.
Route
Tablet, nasal spray or injection
Evidence strength
FDA approved
Desmopressin is a synthetic analog of vasopressin with a stronger effect on urine concentration and a weaker effect on blood pressure. It is sold as DDAVP.
It acts on V2 receptors in the kidney to concentrate urine, and it raises levels of clotting factor VIII and von Willebrand factor.
The FDA has approved desmopressin (DDAVP) for central diabetes insipidus, certain bleeding disorders and bedwetting.
Diabetes insipidus, bedwetting and mild hemophilia A or von Willebrand disease.
Low blood sodium is the main risk and can be serious, so fluid intake is limited.
U.S. FDA prescribing information for Desmopressin. DailyMed, National Library of Medicine.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.